Intellectual Property Magazine
Morrison & Foerster partner Matthew Kreeger and associate Christopher Jamieson Kendall authored “Is there a legislative fix for biotech patents?” for Intellectual Property Magazine. A string of Supreme Court of the United States rulings demonstrate a lack of patent protection for biotech inventions, and SCOTUS efforts to explain its long-held exceptions to Section 101 – laws of nature, physical phenomena, and abstract ideas – have created greater confusion and an increased number of ineligible patents. This article argues that a legislative fix may be the best remedy to the biotech patent issue.
Read the full Intellectual Property Magazine article.